Parenteral Drugs (India) Limited PDPL.NS Stock
Parenteral Drugs (India) Limited Price Chart
Parenteral Drugs (India) Limited PDPL.NS Financial and Trading Overview
Parenteral Drugs (India) Limited stock price | 2.9 INR |
Previous Close | 3 INR |
Open | 3 INR |
Bid | 0 INR x 0 |
Ask | 0 INR x 0 |
Day's Range | 3 - 3 INR |
52 Week Range | 2.85 - 4.8 INR |
Volume | 2.25K INR |
Avg. Volume | 248 INR |
Market Cap | 114.79M INR |
Beta (5Y Monthly) | 0.562328 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -25.61 INR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | September 13, 2010 |
1y Target Est | N/A |
PDPL.NS Valuation Measures
Enterprise Value | 1.16B INR |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 1.3510928 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 13.684 |
Enterprise Value/EBITDA | -7.744 |
Trading Information
Parenteral Drugs (India) Limited Stock Price History
Beta (5Y Monthly) | 0.562328 |
52-Week Change | -4.76% |
S&P500 52-Week Change | 20.43% |
52 Week High | 4.8 INR |
52 Week Low | 2.85 INR |
50-Day Moving Average | 3.22 INR |
200-Day Moving Average | 3.8 INR |
PDPL.NS Share Statistics
Avg. Volume (3 month) | 248 INR |
Avg. Daily Volume (10-Days) | 228 INR |
Shares Outstanding | 29.82M |
Float | 7.06M |
Short Ratio | N/A |
% Held by Insiders | 76.32% |
% Held by Institutions | 0% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1.33333:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2022 |
Next Fiscal Year End | March 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -649.24% |
Gross Margin | 35.67% |
EBITDA Margin | -176.71% |
Management Effectiveness
Return on Assets (ttm) | -6.55% |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | 84.96M INR |
Revenue Per Share (ttm) | 2.85 INR |
Quarterly Revenue Growth (yoy) | -31.00000000000000000000000000000000% |
Gross Profit (ttm) | 30.31M INR |
EBITDA | -150140000 INR |
Net Income Avi to Common (ttm) | -763619008 INR |
Diluted EPS (ttm) | -25.61 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 1K INR |
Total Cash Per Share (mrq) | 0 INR |
Total Debt (mrq) | 1.07B INR |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 0.056 |
Book Value Per Share (mrq) | -276.49 |
Cash Flow Statement
Operating Cash Flow (ttm) | -4827000 INR |
Levered Free Cash Flow (ttm) | 5.26B INR |
Profile of Parenteral Drugs (India) Limited
Country | India |
State | N/A |
City | Indore |
Address | Shree Ganesh Chambers |
ZIP | 452001 |
Phone | 91 73 1409 2000 |
Website | https://www.pdindia.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Parenteral Drugs (India) Limited operates as a healthcare company in India. The company manufactures pharmaceutical products, including intravenous infusion, inhalation, veterinary infusion, etc. It also offers IV fluids, such as carbohydrates and electrolytes, diuretics, dialysis and irrigation solutions, anti-infective and anti-fungal products, and others; and oncology and anaesthesia products. The company also exports its products to Iraq, Yemen, Mozambique, Ghana, Kenya, Kyrgyzstan, Uzbekistan, Sudan, Vietnam, Cambodia, Liberia, Sri Lanka, Nepal, Myanmar, and Cameroon. The company was incorporated in 1983 and is based in Indore, India.
Q&A For Parenteral Drugs (India) Limited Stock
What is a current PDPL.NS stock price?
Parenteral Drugs (India) Limited PDPL.NS stock price today per share is 2.9 INR.
How to purchase Parenteral Drugs (India) Limited stock?
You can buy PDPL.NS shares on the NSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Parenteral Drugs (India) Limited?
The stock symbol or ticker of Parenteral Drugs (India) Limited is PDPL.NS.
Which industry does the Parenteral Drugs (India) Limited company belong to?
The Parenteral Drugs (India) Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Parenteral Drugs (India) Limited have in circulation?
The max supply of Parenteral Drugs (India) Limited shares is 34.85M.
What is Parenteral Drugs (India) Limited Price to Earnings Ratio (PE Ratio)?
Parenteral Drugs (India) Limited PE Ratio is now.
What was Parenteral Drugs (India) Limited earnings per share over the trailing 12 months (TTM)?
Parenteral Drugs (India) Limited EPS is -25.61 INR over the trailing 12 months.
Which sector does the Parenteral Drugs (India) Limited company belong to?
The Parenteral Drugs (India) Limited sector is Healthcare.